Drugs / Retaron®
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02221089 | Jan → Dec 2013 | retinal vascular disorder | Medical University of Vienna | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Retaron | “Dosage 1 capsule Retaron® per day.: Lutein 10mg, Zeaxanthin 2mg, Fishoil 500mg (with 250 mg DHA, 30 mg EPA), Vitamin C 100mg, Zinc 10mg, Selen 25µg, Vitamin E 25mg, Taurin...” NCT02221089 ↗ |
| Modality | Other / unclassified | “Dietary Supplement: Retaron®” NCT02221089 ↗ |
| Route | Oral | “Dosage 1 capsule Retaron® per day.” NCT02221089 ↗ |